TrialEuropean journal of cancer (Oxford, England : 1990)2020

A candidate androgen signalling signature predictive of response to abiraterone acetate in men with metastatic castration-resistant prostate cancer.

Myrto Boukovala et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.